Article Sidebar

Submitted
2 October 2019
Accepted
2 October 2019
Published
3 October 2019
Download
PDF
Statistic
Read Counter : 5419 Download : 2605

Main Article Content

Abstract

Evaluations on Plasma Prothrombin Time (PPT) and Activated Partial Thromboplastin Time (APTT) are required in patients with Chronic Kidney Disease (CKD) stage V to determine the risk of bleeding after hemodialysis (HD) using heparin as the anticoagulant. This study aimed to compare the results of PPT and APTT in pre and post-hemodialysis patients with minimum dose of heparin. This was an observational-analytical study with cross-sectional design. The samples were collected in HD wards of Dr. Soetomo Hospital, Surabaya. There were 50 PPT and APTT samples collected from June to August 2017. The samples were evaluated using the tool CoaDATA 501. The examination of coagulation study was conducted in Clinical Pathology Laboratory of Dr. Soetomo Hospital, Surabaya. Paired t-test and Wilcoxon signed-rank test were performed in this study. In the 50 samples, pre-hemodialysis PPT ranged between 10.2-17.6 with the mean of 12.6±2.03 seconds, while for post-hemodialysis, the range was 10.1-20.9 with the mean of 13.41±2.43 seconds. Pre-hemodialysis APPT ranged between 19.5-75.2 with the mean of 30.32±10.43 seconds, while in post hemodialysis the range was 22.21-175 with the mean of 37.52±26.40 seconds. The results of PTT evaluation in pre and post-HD showed no significant difference (p=0.083), while those of APTT showed a significant difference (p=0.035 or p<0.05). Prolongation of APTT in post-HD is due to the use of heparin as an anticoagulant that increases PPT and APTT by inhibiting antithrombin III. HD procedures cause decreased activity of coagulation factors II, IX, X, XII leading to APTT prolongation in post-HD. A significant APTT prolongation was found in post-HD patients with CKD V.

Keywords

PPT APTT CKD V heparin CoaDATA 501

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Hernaningsih, Y., Widodo, W., & Aprianto, K. (2019). Comparison of PPT and APTT in Pre and Post-Hemodialysis Patients as the Heparin-Exposed Effect. Folia Medica Indonesiana, 55(3), 166–170. https://doi.org/10.20473/fmi.v55i3.15491
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Abdalla SE, Ahmed EM (2014). The effect of haemodialysis on prothrombin time, active partial thromboplastin time, and D dimer in late stage renal failure patients. Sud Med Lab J 2, 27-35
  2. Abdullah KA, Abbas HA (2012). Hematological changes before and after hemodialysis, Scientific Research and Essays Vol. 7(4), pp 490-497, 30 January, 2012
  3. Angus RF (1995). Singapore Polytechnic, Chemical Process & Biotechnology Department, Singapore 0513. 1st Ed. Singapore, p 19-40
  4. Chonchol M, Spiegel DM (2005). Manual of Nephrology. 6th ed. Philadelphia, Lippincott Williams and Wilkins, p 177-186
  5. Clarkson MR, Brenner BM (2009). Pocket companion to brenner & rector's the kidney. 7th Ed. Philadelphia, Elsevier Saunders
  6. Dara KM (2009). Effect of hemodyalisis and peritoneal dialysis on some hematological and biochemical parameters in renal failure. Zanjo J. Med 13
  7. Khalid A, Zafar L (2015). Effect of haemodialysis on mean prothrombin time and activated partial thromboplastin time in patients of end stage renal disease. Journal of Rawalpindi Medical College (JRMC) 19, 247-249
  8. Kim YG (2003). Anticoagulation during hemodyalisis patients at high-risk ofleeding Nephrology, 23-27
  9. Lohr JW, Schwab SJ (2008). Minimizing hemorrhagic complication in dialysis patients. Journal of the American Society of Nephrology 2, 961-75
  10. Mohammed SMA, Muna AB, Leena BM, Fadl AATA, Mekki HA (2008). Hematological changes post hemo and peritoneal dyalisis among renal failure in Sudan, Saudi J Kidney Dis Transpl 19, 274-279
  11. Pandian J, Amitkumar K, Swaminathan A (2017). Assesment of impact hemodyalisis on hematological parameters among patients with chronic kidney disease.Comp Clin Pathol 26, 213-218
  12. Prasanto H (2007). Hypercoagulation in chronic kidney disease. The 7th Jakarta Nephrology & Hypertension Course. PERNEFRI, 25-27
  13. Price SA, Wilson LM (2006). Patofisiologi. 6th Ed. Jakarta, EGC
  14. Sherwood L (2001). Sistem kemih. Fisiologi manusia dari sel ke sistem. 2nd Ed. Jakarta, Penerbit Buku Kedokteran ECG, 463
  15. Sudoyo AW (2009). Penyakit ginjal kronik. Buku Ajar Ilmu Penyakit Dalam. 5th Ed. Jakarta, Pusat Penerbitan IPD FK UI, p 1035-40
  16. Sukandar E (2006). Neurologi klinik. 3rd Ed. Bandung, Pusat Informasi Ilmiah (PII) Bagian Ilmu Penyakit Dalam Fakultas Kedokteran UNPAD
  17. Suwitra K (2006). Penyakit ginjal kronik. In: Sudoyo AW, Setiyohadi B, Alwi I, Marcellus SK, Setiati S, 4th Ed. Jakarta, Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI, p 570-3